Contracts Finder · Award
Covid-19 Flu Vaccine Buffer Stock
A public procurement published by Department of Health and Social Care (DHSC) via Contracts Finder.
- £42.1m
- Award value
- £14m
- Tender value
- 1
- Suppliers
- 3
- Awards
- 3
- Notices
- Award
- Stage
Overview
Contract for the supply of a central national stock of Influenza Vaccine and related storage and distribution services
Key details
- Source
- Contracts Finder
- Lifecycle stage
- Award
- Status
- complete
- CPV classification
- 33651660 — Influenza vaccines
- Currency
- GBP
- Total award value
- £42,122,250
- Tender value
- £14,040,750
- First published
- 22 Nov 2020
- Last updated
- 25 Nov 2020
Awards
3 awards recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Seqirus UK Limited | 09614642 | 24 Sept 2020 | active | £14m |
| Seqirus UK Limited | 09614642 | 24 Sept 2020 | active | £14m |
| Seqirus UK Limited | 09614642 | 24 Sept 2020 | active | £14m |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from Department of Health and Social Care (DHSC)
FAQs about this procurement
Who is the buyer for "Covid-19 Flu Vaccine Buffer Stock"?
Covid-19 Flu Vaccine Buffer Stock is a UK public-sector procurement published by Department of Health and Social Care (DHSC) via Contracts Finder.
Has "Covid-19 Flu Vaccine Buffer Stock" been awarded?
Yes — 3 awards are recorded, with a reported total value of £42,122,250. The current lifecycle stage is "Award".
Which suppliers are involved in "Covid-19 Flu Vaccine Buffer Stock"?
1 supplier is linked: Seqirus UK Limited.
What is "Covid-19 Flu Vaccine Buffer Stock" worth?
The reported award value is £42,122,250.
When was "Covid-19 Flu Vaccine Buffer Stock" published?
It was first published on 22 Nov 2020 and last updated on 25 Nov 2020, across 3 notices.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable